Dr Reddy

Markets crash by over 1,200 points today: Jubilant Pharmova, Thyrocare, Dr Reddy, Pfizer, Dr Lal PathLabs among other healthcare stocks trade in green

Markets crash by over 1,200 points today: Jubilant Pharmova, Thyrocare, Dr Reddy, Pfizer, Dr Lal PathLabs among other healthcare stocks trade in green

After a decline of 1,257.56 points in the opening session, Sensex continued to be volatile. At 3 pm, it was down by 800 points, since the...Read More

Sensex jumps 200 pts in early trade: Reliance Industries, Bharti Airtel, PowerGrid, UltraTech, Dr Reddy's, IndusInd Bank among gainers

Sensex jumps 200 pts in early trade: Reliance Industries, Bharti Airtel, PowerGrid, UltraTech, Dr Reddy's, IndusInd Bank among gainers

Equity benchmark Sensex jumped nearly 200 points in early trade on Wednesday, tracking gains in index heavyweights Reliance Industries, B...Read More

COVID-19: 'Dr Reddy's expects Sputnik V vaccine to get approval from Indian regulator in next few weeks

COVID-19: 'Dr Reddy's expects Sputnik V vaccine to get approval from Indian regulator in next few weeks

Dr Reddy's has partnered with the Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India and other countries

Sensex tanks in early trade: State Bank of India, M&M, Dr Reddy's Lab, Bajaj Auto, Axis Bank, Bajaj Finance, Kotak Bank among others trade in red

Sensex tanks in early trade: State Bank of India, M&M, Dr Reddy's Lab, Bajaj Auto, Axis Bank, Bajaj Finance, Kotak Bank among others trade in red

Equity benchmark Sensex tumbled over 600 points in opening trade on Monday, tracking losses in financial stocks amid foreign fund outflow...Read More

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

For the third consecutive day, the stock market is trading in green. At 12.30 pm, Sensex touched a new high at 50,377.15 points and Nift...Read More

PAT down 30% in Q2; no impact of cyber attack: Dr Reddy's Lab

PAT down 30% in Q2; no impact of cyber attack: Dr Reddy's Lab

The profit after tax (PAT) of Dr Reddys Laboratories Limited for the quarter ended on September 30, 2020, was down by 30 per cent at Rs 7...Read More

Dr Reddy's isolates data centre services after detecting cyber-attack

Dr Reddy's isolates data centre services after detecting cyber-attack

Hyderabad-based drugmaker Dr Reddy's Laboratories Thursday said that it has isolated all data centre services following a cyber-attack.In...Read More

Dr Reddy shares soar by 4.4% after deal with Russia's COVID-19 vaccine developer

Dr Reddy shares soar by 4.4% after deal with Russia's COVID-19 vaccine developer

Shares of Dr Reddy labs soared by 4.4% to Rs 4,639.60 on the BSE after Russian vaccine developer RDIF inked deal with the firm to sell 1...Read More

Dr Reddys PAT down 13% at Rs 579 crore in Q1

Dr Reddys PAT down 13% at Rs 579 crore in Q1

Dr Reddys Laboratories Limitedsconsolidated profit after tax for the quarter ended June 30 was down by 13 per cent to Rs 579.3 crore agai...Read More

COVID-19 drug: After Zydus Cadila and Jubilant Life, Dr. Reddy's signs licensing agreement with Gilead Sciences for Remdesivir

COVID-19 drug: After Zydus Cadila and Jubilant Life, Dr. Reddy's signs licensing agreement with Gilead Sciences for Remdesivir

Dr. Reddy's Laboratories has entered into a non-exclusive licensing agreement with American-based biopharmaceutical company, Gilead Scien...Read More

FDA approves Dr Reddy's NDA for migraine drug

FDA approves Dr Reddy's NDA for migraine drug

Hyderabad: Dr Reddy's Laboratories Ltd said the companys NDA (new drug application) Elyxyb ((celecoxib oral solution 25 mg/mL) has been a...Read More

Equities trade lower, Nifty around 11,900

Equities trade lower, Nifty around 11,900

Mumbai: Equity benchmark indices were in the negative zone during early hours on Wednesday as investors awaited fourth-quarter GDP data d...Read More

Dr Reddy’s Lab acquires Kolkata-based NBFC

Dr Reddy’s Lab acquires Kolkata-based NBFC

New Delhi: Dr Reddy’s Laboratories announced that it has acquired 100 per cent stake in Imperial Credit Private Ltd, a Kolkata-based non-...Read More

placeholder

FIPB to take up 24 foreign investment proposals on Feb 21

New Delhi : FIPB will decide on 24 foreign investment proposals, including those of Vodafone India and Dr Reddy’s Laboratories, on Februa...Read More

Mahindra Ecole Centrale (MEC) hosts TEDx Conference

Mahindra Ecole Centrale (MEC) hosts TEDx Conference

Mahindra Ecole Centrale (MEC), an Indo-French engineering college, hosted TEDx Conference at the campus in Hyderabad. This TEDx Conferenc...Read More

Dr Reddy’s acquires  8 ANDAs in US from Teva Pharma for $350 mn

Dr Reddy’s acquires 8 ANDAs in US from Teva Pharma for $350 mn

Mumbai : Dr Reddy’s Laboratories Ltd has signed an agreement with Teva Pharmaceutical Industries Ltd and an affiliate of Allergan Plc to ...Read More

placeholder

Dr Reddy’s faces US body’s ire

Hyderabad: The US Consumer Product Safety Commission has approached the US Department of Justice seeking action against Dr Reddy’s Labora...Read More

placeholder

Dr Reddy’s Labs board OKs share buyback at Rs 3,500/share

New Delhi : Drug major Dr Reddy’s Laboratories Ltd  will buyback around 44.85 lakh shares, accounting for about 2.6% of the existing paid...Read More

Dr Reddy’s gets USFDA nod for migraine injection

Dr Reddy’s gets USFDA nod for migraine injection

New Delhi: Drug major Dr Reddy’s Laboratories (DRL) has received US health regulator’s approval to market ZembraceSymTouch injection, a d...Read More

Dr Reddy’s slumps 9%, analysts see US FDA issues resolution taking up to 3 yrs

Dr Reddy’s slumps 9%, analysts see US FDA issues resolution taking up to 3 yrs

US FDA’s action may lead to no new active pharma ingredients approvals from the sites under regulatory lens, which may slow down the comp...Read More

Free Press Journal

www.freepressjournal.in